Amphion Innovations plc

Convertible Promisory Note Terms Extended

London and New York, 12 December 2013 - Amphion Innovations plc (LSE: AMP) (“Amphion” or the “Company”), the developer of medical and technology businesses, announces that a meeting of the Unsecured Convertible Promissory Notes 2008-2013 Holders (“Note Holders”) was held on 6 December 2013.  A quorum of the Note Holders was present in person or by proxy at the meeting.  After due consideration it was unanimously resolved that the terms of the Notes be amended such that the due date for settlement be 31 January 2014 rather than 31 December 2013. 

For further information please contact

Amphion Innovations
Charlie Morgan
+1 212 210 6224

Novella Communications
Tim Robertson / Ben Heath
+44 020 3151 7008

Panmure Gordon Limited
Freddy Crossley / Fred Walsh / Grishma Patel (Corporate Finance)
Adam Pollock / Charlie Leigh-Pemberton (Corporate Broking)
+44 020 7886 2500

About Amphion Innovations plc
Amphion (LSE: AMP) builds shareholder value in emerging companies in the medical and technology sectors, by using a focused, hands-on company building approach, based on decades of experience in both the US and UK. Amphion has significant shareholding in 7 Partner Companies developing proven technologies targeting substantial commercial marketplaces. The Amphion model has been refined to optimise the commercialisation of patents and other intellectual property within the Partner Companies. The Partner Companies collectively own or control over 200 separately identified pieces of intellectual property, a number which grows rapidly each year.

On the web: